Windlas Biotech Share Price

Windlas Biotech (INR)1002.95-17.7   (-1.7%)

Exchange ScripsBSE543329NSEWINDLASISININE0H5O01029

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Windlas Biotech Performance

Market performance
Open price1023.9
High1027.75
Volumes25585
Prev Close1002.95
Low997
Closing date2024-10-21
Historical performance
1 Year High1061.15
3 Year High1061.15
5 Year High1061.15
1 Year Low311.60
3 Year Low203.25
5 Year Low203.25

Windlas Biotech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
2088
Face Value
Face Value (₹)
5
P/E Ratio
P/E Ratio
35.85
Dividend Yield
Dividend Yield
0.11 %

Windlas Biotech Investment Returns

1 Year
191.3%
3 Years
201.2%
5 Years
N/A
10 Years
N/A

Windlas Biotech Technicals

IndicatorsValueSignal
5-DMA1007.48Bearish
10-DMA963.87Bullish
20-DMA907.74Bullish
50-DMA876.97Bullish
100-DMA796.54Bullish
200-DMA660.64Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors4569945817512706189368791
Government---------------

Windlas Biotech Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1351006731
Operating Profit916702591578
Interest1181413
Depreciation134124121130
Profit Before Tax771570456217
Consolidated Net Profit582426381158
Adjusted EPS2820179

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital10410510964
Total Reserves4346389038211927
Minority Interest------------
Total Non-Current Liabilities3934236
Total Liabilities6256527048902961
Capital Work in Progress5713876---
Total Assets6256527048902961

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities109061091115
Cash Flow from Investing Activities-921-141-1546-202
Cash Flow from Financing Activitie-153-43713018
Net Cash Inflow / Outflow1631-154-80
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 35.85.
  • 3Y Stock Price CAGR of the stock is 45.3.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹916 Million.
  • The company generated revenue of ₹6310 Million in the previous financial year.

Windlas Biotech

1002.95-17.7   (-1.7%)

Investment Amount: ₹ 32910
Current Value: ₹ 100295
Performence: 204.8%
P/L: ₹ 67385
Top Gainers
SymbolChange%
GFLLIMITED119.34(20%)
DIFFNKG408.3(20%)
SILINV877.1(20%)
PILANIINVS7536.05(20%)
TAINWALCHM280.75(20%)
Top Losers
SymbolChange%
PNCINFRA366.8(-20%)
INDIAMART2508.6(-17%)
RBLBANK176.14(-14%)
WABAG1710(-9%)
JMFINANCIL147.05(-7%)
MITCON107.19(-7%)
TATACONSUM1017.05(-7%)
AETHER862.6(-7%)
Similar stocks

Strides Pharma Scien

27.4

1638.55

September 21 - October 21

RPG Life Sciences

22.3

2749.85

September 21 - October 21

Jagsonpal Pharma

18.8

487.3

September 21 - October 21

Unichem Lab

17.3

757.95

September 21 - October 21

Ipca Laboratories

12.5

1614.35

September 21 - October 21

Gufic Biosciences

10.9

450.15

September 21 - October 21

Medicamen Biotech

10.9

513.3

September 21 - October 21

Solara Active Pharma

9.7

822.35

September 21 - October 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month